Real-time makes a real difference
Get real-time glucose readings sent directly to your smartphone† and customised alerts when you need them - so you can get on with your day uninterrupted. No finger pricks* or waking overnight to scan.
Want to try before you switch? Join the Dexcom Sample Programme and see the life-changing benefits of real-time Continuous Glucose Monitoring (CGM) systems.
† Smart device sold separately.
More accessible than ever before
NICE now recommends that people with type 1 diabetes are offered a choice of glucose sensor, including real-time CGM. 1-2 For people with insulin-treated type 2 diabetes, NICE now recommends that real-time CGM can be considered as an alternative to intermittent scanning. 3
The easiest way to get access is to talk to your Diabetes Healthcare Team and ask for Dexcom.‡
Dexcom is made for more
Dexcom real-time Continuous Glucose Monitoring (CGM) devices are proven to make life easier by lowering HbA1c and increasing time in range by 1 hour 39 minutes per day4 on average. 5-7 All with no scanning, ever.
Download our checklist to help you prepare for discussions around real-time CGM with your Diabetes Healthcare Team.
“We immediately noticed the difference as soon as we applied the Dexcom; It was so light and discrete on our arm! The automatic readings and alerts were an absolute game-changer for us.”
The Diabetic Duo, Dexcom Warriors
@the_diabetic_duo
Made to fit around your lifestyle
With multiple wear locations, customisable alerts and schedules, Dexcom CGM systems allow you to personalise your device to suit you.
Whatever your diabetes needs are, we have a real-time CGM system for you.
Proven accuracy8-10
Real-time makes living with diabetes easier. A recent study4 involving 246 adults with type 1 diabetes proved that, compared to scanning devices, use of a real-time CGM system with a suite of alerts resulted in:
- Increased time in range
- Decreased HbA1c
- Less fear of hypoglycaemia
- Improved well-being
Improved quality of life without scanning
A recent study11 showed that people with diabetes relying on a system that requires scanning were not meeting recommendations for time spent in range,12 despite scanning on average 40 times per day!
How does it work?
Dexcom real-time CGM systems consist of 3 main components:
AUTO-APPLICATOR
Easy insertion with the simple push of a button means people with diabetes can apply the sensor themselves.
SENSOR AND TRANSMITTER
The sensor is inserted just underneath the skin and monitors interstitial glucose levels. The sensors data wirelessly to a display device.†
DISPLAY DEVICE
View real-time glucose data and trends on a compatible smartphone† or an optional receiver.
smart devices sold separately
Ready to make the switch?
Speaking with your Diabetes Healthcare Team is important to ensure you get the right CGM system.
Want to try before you switch? Join the Dexcom Sample Programme and see the life-changing benefits of real-time Continuous Glucose Monitoring (CGM) system.
*if your glucose alerts and readings from a Dexcom CGM system do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
†For a list of compatible smart devices, please visit www.dexcom.com/compatibility. Watch can only be used in conjunction with a compatible smartphone.
‡Access to Dexcom CGM can vary in dierent parts of the UK, for more information talk to your Diabetes Healthcare team.
1 Type 1 diabetes in adults: diagnosis and management. NICE guideline [NG17]. https://www.nice.org.uk/guidance/ng17.
2 Diabetes (type 1 and type 2) in children and young people: diagnosis and management. NICE guideline [NG18]. https://www.nice.org.uk/guidance/ng18.
3 Type 2 diabetes in adults: management. NICE guideline [NG28]. https://www.nice.org.uk/guidance/ng28.
4 Visser MM, et al. Lancet. 2021;397(10291):2275-83.
5 Beck, RW, et al. JAMA. 2017;317(4):371-378.
6 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
7 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.
8 Garg SK, et al. Diabetes Technol Ther. 2022;24(6):373-380.
9 Laffel LM, et al. J Diabetes Sci Technol. 2022:19322968221091816.
10 Shah VN, et al. Diabetes Technol Ther. 2018;20(6):428-433.
11 Lameijer A, et al. Diabetes Res Clin Pract. 2021;177:108897.
12 Battelino T, et al. Diabetes Care. 2019;42(8):1593-1603.
†For a list of compatible smart devices, please visit www.dexcom.com/compatibility. Watch can only be used in conjunction with a compatible smartphone.
‡Access to Dexcom CGM can vary in dierent parts of the UK, for more information talk to your Diabetes Healthcare team.
1 Type 1 diabetes in adults: diagnosis and management. NICE guideline [NG17]. https://www.nice.org.uk/guidance/ng17.
2 Diabetes (type 1 and type 2) in children and young people: diagnosis and management. NICE guideline [NG18]. https://www.nice.org.uk/guidance/ng18.
3 Type 2 diabetes in adults: management. NICE guideline [NG28]. https://www.nice.org.uk/guidance/ng28.
4 Visser MM, et al. Lancet. 2021;397(10291):2275-83.
5 Beck, RW, et al. JAMA. 2017;317(4):371-378.
6 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
7 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.
8 Garg SK, et al. Diabetes Technol Ther. 2022;24(6):373-380.
9 Laffel LM, et al. J Diabetes Sci Technol. 2022:19322968221091816.
10 Shah VN, et al. Diabetes Technol Ther. 2018;20(6):428-433.
11 Lameijer A, et al. Diabetes Res Clin Pract. 2021;177:108897.
12 Battelino T, et al. Diabetes Care. 2019;42(8):1593-1603.